These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 24573252)

  • 1. Genotoxic anti-cancer agents and their relationship to DNA damage, mitosis, and checkpoint adaptation in proliferating cancer cells.
    Swift LH; Golsteyn RM
    Int J Mol Sci; 2014 Feb; 15(3):3403-31. PubMed ID: 24573252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G2/M-Phase Checkpoint Adaptation and Micronuclei Formation as Mechanisms That Contribute to Genomic Instability in Human Cells.
    Kalsbeek D; Golsteyn RM
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29113112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sterigmatocystin-induced checkpoint adaptation depends on Chk1 in immortalized human gastric epithelial cells in vitro.
    Jiang X; Wang J; Xing L; Shen H; Lian W; Yi L; Zhang D; Yang H; Liu J; Zhang X
    Arch Toxicol; 2017 Jan; 91(1):259-270. PubMed ID: 26914363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDRI-9: a novel DNA damage response inhibitor that blocks mitotic progression.
    Jun DW; Hwang M; Kim YH; Kim KT; Kim S; Lee CH
    Oncotarget; 2016 Apr; 7(14):17699-710. PubMed ID: 26848527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptation to DNA damage checkpoint in senescent telomerase-negative cells promotes genome instability.
    Coutelier H; Xu Z; Morisse MC; Lhuillier-Akakpo M; Pelet S; Charvin G; Dubrana K; Teixeira MT
    Genes Dev; 2018 Dec; 32(23-24):1499-1513. PubMed ID: 30463903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting DNA damage in SCLC.
    Foy V; Schenk MW; Baker K; Gomes F; Lallo A; Frese KK; Forster M; Dive C; Blackhall F
    Lung Cancer; 2017 Dec; 114():12-22. PubMed ID: 29173760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Eg5 acts synergistically with checkpoint abrogation in promoting mitotic catastrophe.
    Chen Y; Chow JP; Poon RY
    Mol Cancer Res; 2012 May; 10(5):626-35. PubMed ID: 22522457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Working on Genomic Stability: From the S-Phase to Mitosis.
    Ovejero S; Bueno A; Sacristán MP
    Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32093406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The DNA damage response during mitosis.
    Heijink AM; Krajewska M; van Vugt MA
    Mutat Res; 2013 Oct; 750(1-2):45-55. PubMed ID: 23880065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMP-activated protein kinase (AMPK) beyond metabolism: a novel genomic stress sensor participating in the DNA damage response pathway.
    Sanli T; Steinberg GR; Singh G; Tsakiridis T
    Cancer Biol Ther; 2014 Feb; 15(2):156-69. PubMed ID: 24100703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cell cycle, mitosis and therapeutic applications].
    Levy A; Albiges-Sauvin L; Massard C; Soria JC; Deutsch E
    Bull Cancer; 2011 Oct; 98(9):1037-45. PubMed ID: 21669563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzo[a]pyrene-induced cell cycle arrest in HepG2 cells is associated with delayed induction of mitotic instability.
    Stellas D; Souliotis VL; Bekyrou M; Smirlis D; Kirsch-Volders M; Degrassi F; Cundari E; Kyrtopoulos SA
    Mutat Res; 2014 Nov; 769():59-68. PubMed ID: 25771725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic DNA damage responses: organismal adaptations to genome instability.
    Ermolaeva MA; Schumacher B
    Trends Genet; 2014 Mar; 30(3):95-102. PubMed ID: 24439457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose dependent effects on cell cycle checkpoints and DNA repair by bendamustine.
    Beeharry N; Rattner JB; Bellacosa A; Smith MR; Yen TJ
    PLoS One; 2012; 7(6):e40342. PubMed ID: 22768280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cells enter mitosis with damaged DNA after treatment with pharmacological concentrations of genotoxic agents.
    Kubara PM; Kernéis-Golsteyn S; Studény A; Lanser BB; Meijer L; Golsteyn RM
    Biochem J; 2012 Sep; 446(3):373-81. PubMed ID: 22686412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA damage checkpoints: from initiation to recovery or adaptation.
    Bartek J; Lukas J
    Curr Opin Cell Biol; 2007 Apr; 19(2):238-45. PubMed ID: 17303408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A limited number of double-strand DNA breaks is sufficient to delay cell cycle progression.
    van den Berg J; G Manjón A; Kielbassa K; Feringa FM; Freire R; Medema RH
    Nucleic Acids Res; 2018 Nov; 46(19):10132-10144. PubMed ID: 30184135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell fate determination in cisplatin resistance and chemosensitization.
    Luong KV; Wang L; Roberts BJ; Wahl JK; Peng A
    Oncotarget; 2016 Apr; 7(17):23383-94. PubMed ID: 26993599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptation in replicative senescence: a risky business.
    Coutelier H; Xu Z
    Curr Genet; 2019 Jun; 65(3):711-716. PubMed ID: 30637477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 activates G₁ checkpoint following DNA damage by doxorubicin during transient mitotic arrest.
    Hyun SY; Jang YJ
    Oncotarget; 2015 Mar; 6(7):4804-15. PubMed ID: 25605022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.